NCT02492321View on ClinicalTrials.gov

A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Allergic Conjunctivitis (AC)
Interventions
DRUG

EBI-005

DRUG

Placebo Comparator

Trial Locations (11)

19134

Investigational Site, Philadelphia

28204

Charlotte

30260

Morrow

38119

Memphis

40206

Louisville

45040

Investigational Site, Mason

45238

Investigational Site, Cincinnati

63131

Investigational Site, St Louis

78209

San Antonio

01810

Andover

02169

Investigational Site, Quincy

Sponsors
All Listed Sponsors
lead

Eleven Biotherapeutics

INDUSTRY